Remimazolam anesthesia enabled stable hemodynamics and successful immediate extubation without complications in a 2-year-old undergoing the Fontan procedure.
Is remimazolam a feasible and safe sedative option during the Fontan procedure?
Remimazolam may be a feasible and safe sedative option for general anesthesia during the Fontan procedure, allowing for stable hemodynamics and early extubation.
Absolute Event Rate: 0% vs 0%
The Fontan procedure requires anesthetics, allowing rapid awakening for early extubation and less circulatory depression owing to passive pulmonary blood flow hemodynamics. Remimazolam, a short-acting benzodiazepine, may be a suitable anesthetic choice; however, its use in this procedure is unreported. We present a 2-year-old boy with a single-right ventricle and pulmonary valve stenosis who underwent the Fontan procedure under anesthesia with remimazolam (3–8 mg kg − 1 h − 1 ) and fentanyl (21.8 μg/kg). Hemodynamics remained stable under electroencephalographic monitoring, and the patient was extubated in the operating room without any complications. Therefore, remimazolam may be a feasible sedative option during the Fontan procedure.
Shimizu et al. (Sun,) reported a other. Remimazolam anesthesia enabled stable hemodynamics and successful immediate extubation without complications in a 2-year-old undergoing the Fontan procedure.